ClinicalTrials.Veeva

Menu
G

GTL Medical and Research Group | Miami, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Lumateperone
Enpatoran
Aticaprant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 5 total trials

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

The purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active...

Enrolling
Cutaneous Lupus Erythematosus
Systematic Lupus Erythematosus
Drug: Placebo
Drug: Enpatoran

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients who are experiencing major depressive episodes (MDEs)...

Enrolling
Bipolar Depression
Drug: Lumateperone
Drug: Placebo

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irrita...

Enrolling
Irritability Associated With Autism Spectrum Disorder
Drug: Lumateperone low dose
Drug: Lumateperone high dose

This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophren...

Enrolling
Autism Spectrum Disorder
Schizophrenia
Drug: Lumateperone

Trial sponsors

Intra-Cellular Therapies logo
Janssen (J&J Innovative Medicine) logo
Merck KGaA (EMD Serono) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems